By Iain Gilbert
Date: Wednesday 25 Jun 2025
(Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company.
4basebio Plc - Result of AGM | 27-Jun-2025 | 18:05 | PR Newswire |
AGM Statement | 27-Jun-2025 | 14:38 | RNS |
Completed acquisition of remaining 12% in China JV | 27-Jun-2025 | 10:00 | RNS |
Holding(s) in Company | 27-Jun-2025 | 08:54 | RNS |
Holding(s) in Company | 27-Jun-2025 | 08:30 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 20,037.82 |
Closing Price Change | 143.16 |
% Change | 0.72 % |
27-Jun-25 Close | 20,037.82 |
You are here: research